EA201991165A1 - METHODS FOR STRENGTHENING AN IMMUNE RESPONSE USING EVEROLIMUS, DACTOLISIB OR BOTH - Google Patents

METHODS FOR STRENGTHENING AN IMMUNE RESPONSE USING EVEROLIMUS, DACTOLISIB OR BOTH

Info

Publication number
EA201991165A1
EA201991165A1 EA201991165A EA201991165A EA201991165A1 EA 201991165 A1 EA201991165 A1 EA 201991165A1 EA 201991165 A EA201991165 A EA 201991165A EA 201991165 A EA201991165 A EA 201991165A EA 201991165 A1 EA201991165 A1 EA 201991165A1
Authority
EA
Eurasian Patent Office
Prior art keywords
immune response
dactolisib
everolimus
strengthening
methods
Prior art date
Application number
EA201991165A
Other languages
Russian (ru)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/001579 external-priority patent/WO2018096402A1/en
Publication of EA201991165A1 publication Critical patent/EA201991165A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)

Abstract

Настоящее изобретение относится к способу усиления иммунного ответа у пациента.The present invention relates to a method for enhancing an immune response in a patient.

EA201991165A 2017-10-24 2017-11-22 METHODS FOR STRENGTHENING AN IMMUNE RESPONSE USING EVEROLIMUS, DACTOLISIB OR BOTH EA201991165A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762576511P 2017-10-24 2017-10-24
PCT/IB2017/001579 WO2018096402A1 (en) 2016-11-23 2017-11-22 Methods of enhancing immune response with everolimus, dactolisib or both

Publications (1)

Publication Number Publication Date
EA201991165A1 true EA201991165A1 (en) 2019-11-29

Family

ID=68653631

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991165A EA201991165A1 (en) 2017-10-24 2017-11-22 METHODS FOR STRENGTHENING AN IMMUNE RESPONSE USING EVEROLIMUS, DACTOLISIB OR BOTH

Country Status (1)

Country Link
EA (1) EA201991165A1 (en)

Similar Documents

Publication Publication Date Title
MX2019007021A (en) Il-11ra antibodies.
MX2019007020A (en) Il-11 antibodies.
MD3369425T2 (en) Compositions comprising bacterial strains
PH12016502142B1 (en) Anti-ptk7 antibody-drug conjugates
SG10201803042PA (en) Anti-tim-3 antibodies
EA201791029A1 (en) ANTIBODIES AGAINST INTERLEUKIN-33 AND THEIR APPLICATION
MX2018000778A (en) Methods for treating hepcidin-mediated disorders.
BR112018005409A2 (en) glycodirectional therapy.
EA201890747A1 (en) METHODS OF TREATING INFLAMMATORY DISEASES
MX2023006415A (en) Antibodies, uses & methods.
TR201910057T4 (en) RUBBER COMPOSITIONS
MX2021007245A (en) Microorganism for producing putrescine or ornithine and method for producing putrescine or ornithine by using same.
MY190747A (en) Method for producing silazane-siloxane copolymers and the use of such copolymers
IT201700027605A1 (en) Photovoltaic apparatus.
EA201792058A1 (en) VIROTHERAPY BY ANTIBODY COMBINATION
EA201692534A1 (en) METHODS OF TREATMENT OF HYPOTHONY
DK3402782T3 (en) 8-AMINO-2-OXO-1,3-DIAZA-SPIRO- [4.5] -DECANDERIVATER
AU2016362202A8 (en) Method for preventing or treating nosocomial pneumonia
IL266750A (en) Methods of enhancing immune response with everolimus, dactolisib or both
DK3402783T3 (en) 3- (carboxyethyl) -8-amino-2-oxo-1,3-diaza-spiro [4.5] decane-DERIVATIVES
EA201991165A1 (en) METHODS FOR STRENGTHENING AN IMMUNE RESPONSE USING EVEROLIMUS, DACTOLISIB OR BOTH
MX2020003611A (en) Methods for wellbore strengthening.
CL2019000700S1 (en) Induction heater application
TN2014000522A1 (en) لوح مدرسي بوجهين
IT201700109107A1 (en) TAPIS ROULANT, IN PARTICULAR FOR HYPOVED / NON-VISITING PERSONS